Tamoxifen mutagenesis and carcinogenesis in livers of lambda/lacI transgenic rats: selective influence of phenobarbital promotion
Authors:
- 18 December 2000
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 162 (1) , 117-122
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI: Journal of the National Cancer Institute, 1998
- Clastogenic and aneugenic effects of tamoxifen and some of its analogues in hepatocytes from dosed rats and in human lymphoblastoid cells transfected with human P450 cDNAs (MCL-5 cells)Carcinogenesis, 1997
- Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley ratsCarcinogenesis, 1996
- DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formationCarcinogenesis, 1995
- Genotoxicity of tamoxifen epoxide and toremifene in human lymphoblastoid cells containing human cytochrome P450sCarcinogenesis, 1994
- Tamoxifen induces hepatocellular carcinoma in rat liver: A 1-year study with two antiestrogensArchives of Toxicology, 1993
- Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cellsCarcinogenesis, 1992
- Long-term prophylactic use of tamoxifenEuropean Journal Of Cancer Prevention, 1992
- Synthetic estrogens and tamoxifen as promoters of hepatocarcinogenesisPreventive Medicine, 1991
- Induction and promotion of γ-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associationsCancer Letters, 1989